company background image
NMRD logo

Nemaura Medical OTCPK:NMRD Stock Report

Last Price

US$0.089

Market Cap

US$2.3m

7D

21.6%

1Y

-89.9%

Updated

28 Mar, 2024

Data

Company Financials +

NMRD Stock Overview

Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States.

NMRD fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Nemaura Medical Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Nemaura Medical
Historical stock prices
Current Share PriceUS$0.089
52 Week HighUS$1.25
52 Week LowUS$0.068
Beta-0.096
1 Month Change2.30%
3 Month Change-59.36%
1 Year Change-89.89%
3 Year Change-98.81%
5 Year Change-99.14%
Change since IPO-96.44%

Recent News & Updates

Recent updates

Nemaura Medical GAAP EPS of -$0.17

Aug 15

Nemaura Medical GAAP EPS of -$0.59 misses by $0.12, revenue of $0.51M

Jun 30

Nemaura Medical: Opportunity In The Consumer-Centered Continuous Glucose Monitoring Market

Mar 10

Nemaura Medical (NASDAQ:NMRD) Has Debt But No Earnings; Should You Worry?

Nov 17
Nemaura Medical (NASDAQ:NMRD) Has Debt But No Earnings; Should You Worry?

Nemaura Medical: From Believer To Skeptic

Sep 20

Nemaura: Wearable Monitoring Patches For Type-2 Diabetics Could Be An Inspired Move

Jul 02

Nemaura Medical rallies on 200K sugarBEAT sensors order

May 05

Nemaura Medical: Lowering Glucose Levels Will Increase Share Price

Feb 03

How Much Of Nemaura Medical Inc. (NASDAQ:NMRD) Do Insiders Own?

Dec 22
How Much Of Nemaura Medical Inc. (NASDAQ:NMRD) Do Insiders Own?

Shareholder Returns

NMRDUS Medical EquipmentUS Market
7D21.6%2.3%0.2%
1Y-89.9%12.8%28.1%

Return vs Industry: NMRD underperformed the US Medical Equipment industry which returned 13.3% over the past year.

Return vs Market: NMRD underperformed the US Market which returned 28.8% over the past year.

Price Volatility

Is NMRD's price volatile compared to industry and market?
NMRD volatility
NMRD Average Weekly Movement24.1%
Medical Equipment Industry Average Movement7.7%
Market Average Movement6.1%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.0%

Stable Share Price: NMRD's share price has been volatile over the past 3 months.

Volatility Over Time: NMRD's weekly volatility (24%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
200936Faz Chowdhuryhttps://nemauramedical.com

Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs.

Nemaura Medical Inc. Fundamentals Summary

How do Nemaura Medical's earnings and revenue compare to its market cap?
NMRD fundamental statistics
Market capUS$2.31m
Earnings (TTM)-US$10.65m
Revenue (TTM)n/a

0.0x

P/S Ratio

-0.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NMRD income statement (TTM)
RevenueUS$0
Cost of RevenueUS$1.48m
Gross Profit-US$1.48m
Other ExpensesUS$9.17m
Earnings-US$10.65m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.37
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio-110.2%

How did NMRD perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.